Bausch Health (BHC) reported $2.52 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 11.7%. EPS of $0.78 for the same period compares to $0.59 a year ago.

Bausch Health (BHC) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.59 per share a year ago. These figures ...

We just covered the Billionaire Howard Marks’ 10 Stock Picks with Huge Upside Potential and Bausch Health Companies Inc. (NYSE:BHC) ranks 1st on this list. Bausch Health Companies Inc. (NYSE:BHC) has ...

The Quebec, Quebec-based company said it had a loss of $3.82 per share. Earnings, adjusted for asset impairment costs and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Bausch + Lomb, a company that started as a small optical goods shop in upstate New York and grew to become a global ophthalmic products business, is returning to the public markets. The company has ...

Investors in Bausch Health Companies Inc (Symbol: BHC) saw new options begin trading today, for the January 2028 expiration. One of the key inputs that goes into the price an option buyer is willing ...

Bausch Health Companies (NYSE: BHC), formerly Valeant Pharmaceuticals, has seen its share price rally more than 50% over the last two months. There were 2 main reasons for this: The company’s share ...